Unsolicited R24 for the CFAR-Network of Integrated Clinical Sciences, CNICS
CNICS 综合临床科学 CFAR 网络主动提供的 R24
基本信息
- 批准号:8121744
- 负责人:
- 金额:$ 13.82万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-09-07 至 2011-08-31
- 项目状态:已结题
- 来源:
- 关键词:AIDS/HIV problemAcquired Immunodeficiency SyndromeAddressAdherenceAffectAwardBasic ScienceBehavioralBehavioral SciencesBioethicsBiologicalCaringCessation of lifeClinicClinicalClinical DataClinical InvestigatorClinical SciencesClinical TreatmentClinical TrialsCohort StudiesCollaborationsCollectionCombined Modality TherapyCommitComplementComputer softwareComputerized Medical RecordDataData AnalysesData CollectionData ElementData QualityData SetDatabasesDevelopmentDisease ManagementDisease ProgressionDocumentationEpidemicEpidemiologyEventFosteringFutureGoalsHIVHIV InfectionsHighly Active Antiretroviral TherapyIndividualInformation SystemsInterviewLinkMeasuresMedical InformaticsMedical RecordsMethodologyMethodsMonoclonal Antibody R24MorphologyNatural HistoryOutcomeOutcomes ResearchPathogenesisPatient CarePatientsPoint-of-Care SystemsPositioning AttributePrincipal InvestigatorProceduresQuality ControlQuestionnairesRandomized Controlled Clinical TrialsReportingResearchResearch InfrastructureResearch PersonnelResource DevelopmentResourcesSamplingSiteSoftware ToolsSourceSpecimenStandardizationStructureSubstance abuse problemSystemSystems IntegrationToxic effectUnited StatesWorkabstractingantiretroviral therapybaseclinical careclinical decision-makingclinical research sitecohortdata sharingflexibilityimmune functionnovelnovel strategiespoint of carepopulation basedprospectiverepositoryresponsesuccesssystems researchtransmission process
项目摘要
DESCRIPTION (provided by applicant):
The clinical treatment of HIV/AIDS in the era of Highly Active Anti-Retroviral Therapy (HAART) is extremely dynamic with unprecedented combinations of therapies and a myriad of patient and virologic responses to therapy. Long-term outcomes research is necessary to provide clinicians with up-to-date information on the best strategies to employ in their patients' individual situations. Historically, evidence for clinical care decisions has been generated through the conduct of randomized controlled clinical trials, epidemiology-based prospective clinical cohorts, and anecdotal reports. A new approach that will synergize with these methods is outcomes research based on the utilization of data derived directly from newly developed electronic medical record (EMR) systems and compiling such data into novel research networks. Such EMR systems are already in existence at several Centers for AIDS Research (CFAR) sites in the United States.
The CFAR Network of Integrated Clinical Systems (CNICS) project is the first such resource network that can substantially contribute to the contemporary HIV research agenda. As a clinic-based research network, CNICS directly reflects the outcomes of clinical decisions and management options used daily in the care of HIV infected individuals. Unlike data collected in structured interviews or through retrospective medical record review, CNICS assures a broader range of information associated with the rapidly changing course of HIV disease management through collection of data at the point of care. The CNICS project supports a data system that is a central repository of verified and quality-controlled data from the EMRs at seven CFAR sites. The EMR data recorded for individual patient care are made available through CNICS for population-based outcomes research, which facilitates networking and contributes to the standardization of data contained in the CNICS data system. CNICS is also developing a specimen repository linked with clinical data from the sites' EMRs.
CNICS is a unique resource for HIV clinical, translational, and basic research and will provide the
infrastructure and data to address the challenging and rapidly evolving issues in HIV care and research. The principle goals of this proposal are to build and support the CNICS infrastructure, to address the challenging research agenda of the evolving HIV epidemic, to prepare for the expansion of CNICS by developing standard operating procedures and software tools to facilitate data quality control and transmission, to expand CNICS by 8 to 10 sites within 5 years, and to serve as a resource for the development of similar research networks.
描述(由申请人提供):
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Michael S. Saag其他文献
Impact of Depression and HIV Symptoms on Glycemic Outcomes among Patients with HIV and Type 2 Diabetes: A Clinical Cohort Study
- DOI:
10.1007/s10461-025-04653-7 - 发表时间:
2025-02-17 - 期刊:
- 影响因子:2.400
- 作者:
Veronica Joyce Brady;Amanda L. Willig;Katerina A. Christopoulos;David J. Grelotti;George A. Yendewa;Conall O’Cleirigh;Richard D. Moore;Sonia Napravnik;Allison Webel;Heidi M. Crane;Michael S. Saag;Stephanie A Ruderman - 通讯作者:
Stephanie A Ruderman
Treatment of Histoplasmosis and Blastomycosis
- DOI:
10.1378/chest.93.4.848 - 发表时间:
1988-04-01 - 期刊:
- 影响因子:
- 作者:
Michael S. Saag;William E. Dismukes - 通讯作者:
William E. Dismukes
Correction: Severity and Number of Substances Used are Independently Associated with Antiretroviral Therapy Adherence Over Time Among People with HIV in the Current Treatment Era
- DOI:
10.1007/s10461-024-04566-x - 发表时间:
2024-12-03 - 期刊:
- 影响因子:2.400
- 作者:
Jimmy Ma;Joseph A. C. Delaney;Stephanie A. Ruderman;Robin M. Nance;Andrew W. Hahn;Lydia N. Drumright;Bridget M. Whitney;Rob J. Fredericksen;L. Sarah Mixson;Joseph O. Merrill;Steven A. Safren;Kenneth H. Mayer;Conall O’Cleirigh;Sonia Napravnik;Geetanjali Chander;Richard D. Moore;Katerina A. Christopoulos;Amanda L. Willig;Laura Bamford;Allison Webel;Mary E. McCaul;Edward R. Cachay;Jeffrey M. Jacobson;Michael S. Saag;Mari M. Kitahata;Heidi M. Crane;Emily C. Williams - 通讯作者:
Emily C. Williams
Major expansion of CD8+ T cells with a predominant Vβ usage during the primary immune response to HIV
在对 HIV 的初次免疫应答期间,具有主要 Vβ 使用情况的 CD8+T 细胞的主要扩增
- DOI:
10.1038/370463a0 - 发表时间:
1994-08-11 - 期刊:
- 影响因子:48.500
- 作者:
Giuseppe Pantaleo;James F. Demarest;Hugo Soudeyns;Cecilia Graziosi;François Denis;Joseph W. Adelsberger;Persephone Borrow;Michael S. Saag;George M. Shaw;Rafick P. Sekalytt;Anthony S. Fauci - 通讯作者:
Anthony S. Fauci
Correction to: Genetic architecture of cardiometabolic risks in people living with HIV
对“HIV 感染者心脏代谢风险的遗传结构”的更正
- DOI:
10.1186/s12916-021-01976-9 - 发表时间:
2021-05-05 - 期刊:
- 影响因子:8.300
- 作者:
Haoxiang Cheng;Anshuman Sewda;Carla Marquez-Luna;Sierra R. White;Bridget M. Whitney;Jessica Williams-Nguyen;Robin M. Nance;Won Jun Lee;Mari M. Kitahata;Michael S. Saag;Amanda Willig;Joseph J. Eron;W. Christopher Mathews;Peter W. Hunt;Richard D. Moore;Allison Webel;Kenneth H. Mayer;Joseph A. Delaney;Paul K. Crane;Heidi M. Crane;Ke Hao;Inga Peter - 通讯作者:
Inga Peter
Michael S. Saag的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Michael S. Saag', 18)}}的其他基金
INCIDENCE, PREDICTORS, AND CLINICAL OUTCOMES OF SARS-CoV-2 INFECTION IN PERSONS WITH HIV
HIV 感染者感染 SARS-CoV-2 的发病率、预测因素和临床结果
- 批准号:
10305900 - 财政年份:2021
- 资助金额:
$ 13.82万 - 项目类别:
Integration of Evidence-based Alcohol Interventions into HIV Care
将循证酒精干预措施纳入艾滋病毒护理
- 批准号:
8330815 - 财政年份:2011
- 资助金额:
$ 13.82万 - 项目类别:
Integration of Evidence-based Alcohol Interventions into HIV Care
将循证酒精干预措施纳入艾滋病毒护理
- 批准号:
8529402 - 财政年份:2011
- 资助金额:
$ 13.82万 - 项目类别:
Integration of Evidence-based Alcohol Interventions into HIV Care
将循证酒精干预措施纳入艾滋病毒护理
- 批准号:
8720633 - 财政年份:2011
- 资助金额:
$ 13.82万 - 项目类别:
Integration of Evidence-based Alcohol Interventions into HIV Care
将循证酒精干预措施纳入艾滋病毒护理
- 批准号:
8211871 - 财政年份:2011
- 资助金额:
$ 13.82万 - 项目类别:
Unsolicited R24 for the CFAR-Network of Integrated Clinical Sciences, CNICS
CNICS 综合临床科学 CFAR 网络主动提供的 R24
- 批准号:
7926709 - 财政年份:2009
- 资助金额:
$ 13.82万 - 项目类别:
相似海外基金
RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
- 批准号:
10219039 - 财政年份:2020
- 资助金额:
$ 13.82万 - 项目类别:
RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
- 批准号:
9981476 - 财政年份:2019
- 资助金额:
$ 13.82万 - 项目类别:
IGF::OT::IGF RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
IGF::OT::IGF 针对获得性免疫缺陷综合症分类的研究支持服务
- 批准号:
9364184 - 财政年份:2016
- 资助金额:
$ 13.82万 - 项目类别:
Human Immunodeficiency Virus (HIV) and Acquired Immunodeficiency Syndrome (AIDS) in Saskatchewan- Where are we now and what does the future hold?
萨斯喀彻温省的人类免疫缺陷病毒(HIV)和获得性免疫缺陷综合症(艾滋病)——我们现在在哪里以及未来会怎样?
- 批准号:
236932 - 财政年份:2011
- 资助金额:
$ 13.82万 - 项目类别:
Miscellaneous Programs
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
- 批准号:
3554155 - 财政年份:1991
- 资助金额:
$ 13.82万 - 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
- 批准号:
3554156 - 财政年份:1991
- 资助金额:
$ 13.82万 - 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW
获得性免疫缺陷综合症研究综述
- 批准号:
2063342 - 财政年份:1991
- 资助金额:
$ 13.82万 - 项目类别:














{{item.name}}会员




